Cargando…

Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol

INTRODUCTION: Despite being more than two decades of research, mesenchymal stromal cell (MSC) treatments are still struggling to cross the translational gap. Two key issues that likely contribute to these failures are (1) the lack of clear definition for MSC and (2) poor quality of reporting in MSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Renesme, Laurent, Cobey, Kelly D, Le, Maxime, Lalu, Manoj M, Thebaud, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499309/
https://www.ncbi.nlm.nih.gov/pubmed/34620674
http://dx.doi.org/10.1136/bmjopen-2021-054740
_version_ 1784580301196886016
author Renesme, Laurent
Cobey, Kelly D
Le, Maxime
Lalu, Manoj M
Thebaud, Bernard
author_facet Renesme, Laurent
Cobey, Kelly D
Le, Maxime
Lalu, Manoj M
Thebaud, Bernard
author_sort Renesme, Laurent
collection PubMed
description INTRODUCTION: Despite being more than two decades of research, mesenchymal stromal cell (MSC) treatments are still struggling to cross the translational gap. Two key issues that likely contribute to these failures are (1) the lack of clear definition for MSC and (2) poor quality of reporting in MSC clinical studies. To address these issues, we propose a modified Delphi study to establish a consensus definition for MSC and reporting guidelines for clinical trials of MSC therapy. METHODS AND ANALYSIS: We will conduct a three-round international modified Delphi survey. Findings from a recent scoping review examining how MSCs are defined and reported in preclinical and clinical studies were used to draft the initial survey for round 1 of our Delphi. Participants will include a ‘core group’ of individuals as well as researchers whose work was captured in our scoping review. The core group will include stakeholders from different research fields including developmental biology, translational science, research methods, regulatory practices, scholarly journal editing and industry. The first two survey rounds will be online, and the final round will take place in person. Each participant will be asked to rate their agreement on potential MSC definition characteristics and reporting items using a Likert scale. After each round, we will analyse the data to determine which items have reached consensus for inclusion/exclusion, and then develop a revised questionnaire for any new items, or items that did not reach consensus. ETHICS AND DISSEMINATION: This study received ethical approval from the Ottawa Health Research Network Research Ethics Board. To support the dissemination of our findings, we will use an evidence-based ‘integrated knowledge translation’ approach to engage knowledge users from the inception of the research. This will allow us to develop a tailored end-of-project knowledge translation plan to support and ensure dissemination and implementation of the Delphi results.
format Online
Article
Text
id pubmed-8499309
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-84993092021-10-22 Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol Renesme, Laurent Cobey, Kelly D Le, Maxime Lalu, Manoj M Thebaud, Bernard BMJ Open Research Methods INTRODUCTION: Despite being more than two decades of research, mesenchymal stromal cell (MSC) treatments are still struggling to cross the translational gap. Two key issues that likely contribute to these failures are (1) the lack of clear definition for MSC and (2) poor quality of reporting in MSC clinical studies. To address these issues, we propose a modified Delphi study to establish a consensus definition for MSC and reporting guidelines for clinical trials of MSC therapy. METHODS AND ANALYSIS: We will conduct a three-round international modified Delphi survey. Findings from a recent scoping review examining how MSCs are defined and reported in preclinical and clinical studies were used to draft the initial survey for round 1 of our Delphi. Participants will include a ‘core group’ of individuals as well as researchers whose work was captured in our scoping review. The core group will include stakeholders from different research fields including developmental biology, translational science, research methods, regulatory practices, scholarly journal editing and industry. The first two survey rounds will be online, and the final round will take place in person. Each participant will be asked to rate their agreement on potential MSC definition characteristics and reporting items using a Likert scale. After each round, we will analyse the data to determine which items have reached consensus for inclusion/exclusion, and then develop a revised questionnaire for any new items, or items that did not reach consensus. ETHICS AND DISSEMINATION: This study received ethical approval from the Ottawa Health Research Network Research Ethics Board. To support the dissemination of our findings, we will use an evidence-based ‘integrated knowledge translation’ approach to engage knowledge users from the inception of the research. This will allow us to develop a tailored end-of-project knowledge translation plan to support and ensure dissemination and implementation of the Delphi results. BMJ Publishing Group 2021-10-07 /pmc/articles/PMC8499309/ /pubmed/34620674 http://dx.doi.org/10.1136/bmjopen-2021-054740 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Research Methods
Renesme, Laurent
Cobey, Kelly D
Le, Maxime
Lalu, Manoj M
Thebaud, Bernard
Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
title Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
title_full Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
title_fullStr Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
title_full_unstemmed Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
title_short Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
title_sort establishment of a consensus definition for mesenchymal stromal cells (msc) and reporting guidelines for clinical trials of msc therapy: a modified delphi study protocol
topic Research Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499309/
https://www.ncbi.nlm.nih.gov/pubmed/34620674
http://dx.doi.org/10.1136/bmjopen-2021-054740
work_keys_str_mv AT renesmelaurent establishmentofaconsensusdefinitionformesenchymalstromalcellsmscandreportingguidelinesforclinicaltrialsofmsctherapyamodifieddelphistudyprotocol
AT cobeykellyd establishmentofaconsensusdefinitionformesenchymalstromalcellsmscandreportingguidelinesforclinicaltrialsofmsctherapyamodifieddelphistudyprotocol
AT lemaxime establishmentofaconsensusdefinitionformesenchymalstromalcellsmscandreportingguidelinesforclinicaltrialsofmsctherapyamodifieddelphistudyprotocol
AT lalumanojm establishmentofaconsensusdefinitionformesenchymalstromalcellsmscandreportingguidelinesforclinicaltrialsofmsctherapyamodifieddelphistudyprotocol
AT thebaudbernard establishmentofaconsensusdefinitionformesenchymalstromalcellsmscandreportingguidelinesforclinicaltrialsofmsctherapyamodifieddelphistudyprotocol